Abstract
Twenty six adult patients were treated with high dose intravenous immuneglobulin (Endobulin-Immuno) for idiopathic membranous nephropathy and nephrotic syndrome.Pulse doses of 0.4 g/Kg b. wt. for 3 consecutive days were given and repeated twice after 3 weeks. Afterwards, one pulse dose every 3 weeks has been administered for a 12 months period. At the end of the study, 11 patients had a complete remission (daily proteinuria <0.2 g), 8 patients had a partial remission (daily proteinuria ≤3.5 g. mean 2.27±0.6 g).On the whole, 19 responders (73%) and 7 non-responders (27%).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Imbach, P., Barandun, S., d’Apuzzo, V., Baumgartner, C., Hirt, A., Morell, A., Rosi, E., Schoni, M., Wagner, H. P. Lancet i, 1228–1231, 1981.
Ponticelli, C., Zucchelli, P., Passerini, P., Cagnoli, L., Cesana, B., Pozzi, C., Pasquali, S., Imbasciati, E., GRassi, C., Redaelli, B., Sasdelli M., Locatelli, F. New Eng J Med 320, 8–13, 1989.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Palla, R. et al. (1991). High Dose Intravenous Human IgG in the Treatment of Idiopathic Membranous Nephropathy: Preliminary Report of a Multicentric Trial. In: Andreucci, V.E., Dal Canton, A. (eds) New Therapeutic Strategies in Nephrology. Developments in Nephrology, vol 30. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3884-4_13
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3884-4_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6732-1
Online ISBN: 978-1-4615-3884-4
eBook Packages: Springer Book Archive